Danshen injection in the treatment of silent myocardial ischemic coronary heart disease 60 Cases.docVIP
- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Danshen injection in the treatment of silent myocardial ischemic coronary heart disease 60 Cases
PAGE \* MERGEFORMAT 4
Danshen injection in the treatment of silent myocardial ischemic coronary heart disease 60 Cases
[Keywords:] compound Danshen injection of silent myocardial ischemic coronary heart disease observation
Coronary heart disease is common in the elderly, frequently-occurring disease, not only high incidence, but also one of angina, myocardial infarction, mortality is very high, serious harm to people’s health, early treatment and be prevention. Over the past year, we apply the compound Danshen injection on 60 patients with silent myocardial ischemic short-term treatment in patients with coronary heart disease, receive good clinical results, are summarized below.
1 Materials and Methods
1.1 Case Data 120 patients with coronary heart disease in this group are in line with WHO’s 1979 silent myocardial ischemic coronary heart disease diagnostic criteria, patients with asymptomatic, but the rest, the dynamic stress test or electrocardiogram showed ST segment depression, T wave reduction, such as flattening or inversion of the objective evidence of myocardial ischemia; or inadequate myocardial perfusion performance of myocardial perfusion imaging. randomly divided into two groups: treatment group 60 cases, 39 males and 21 females, aged 43 to 88 years, mean age 61 years; the control group 60 cases, 37 males and 23 females, aged 42 to 85 years, mean age 60 years. two groups of gender, age, objective evidence, the statistical difference was not statistically significant ( P lt;0.05), comparable.
1.2 treatment based on conventional therapy, the treatment group to the compound Danshen injection 250ml infusion, day 1, the control group received intravenous infusion of hydrochloric acid ligustrazine 85mg, day 1, two groups were 14 days to 1 a course of treatment.
1.3 determine the efficacy of the basic recovery: resting and dynamic load test or ECG ST-segment depression disappeared, or depression lt;0.05mV, flat or inverted T wave into th
您可能关注的文档
- Cystectomy ileal neobladder Perioperative Nursing.doc
- Cystitis glandularis OK bilateral ureteral bladder exclusion of skin ostomy Report of 1 case.doc
- Cytidine triphosphate plus dexamethasone Efficacy of treatment of sudden deafness.doc
- Cytochrome oxidase P4502C19 Research Progress.doc
- Cytochrome P450 3A4 epitope analysis and preparation of antibodies and identification of.doc
- Cytochrome P450 research in progress in cancer therapy.doc
- Cystostomy in patients with senile dementia of the home care.doc
- Cytokeratins in normal skin tissues.doc
- Cytokine signal transduction inhibitor 1 (SOCS 1) Research Progress.doc
- Cytokines and systemic lupus erythematosus.doc
- Danshen injection on blood coagulation in patients with systemic inflammatory response syndrome function of.doc
- Danqi kidney side combined with benazepril treatment of early diabetic nephropathy_0.doc
- Danshen injection on chronic obstructive pulmonary disease model rat transforming growth factor β1 in_0.doc
- Danshen injection on gene expression of rheumatoid arthritis Discussion of feasibility analysis.doc
- Danshen injection on early renal damage in gout the impact of effective plasma flow.doc
- Danshen injection on rat mesenteric microcirculation.doc
- Danshen injection on chronic obstructive pulmonary disease model rat transforming growth factor β1 in.doc
- Danshen sustained-release tablets of borneol inclusion technology.doc
- Danshensu on the capsule and the determination of protocatechuic aldehyde.doc
- Danshen injection on renal function in rats with obstructive nephropathy and TGFβ 1 expression.doc
文档评论(0)